Gatoc, Emma S.
HRN: 03-37-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2022
MUPIROCIN 2%, 15G (TUBE)
05/09/2022
05/15/2022
TOPICAL
15gm
BID
Decubitus Ulcer Stage 1
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes